Drug news
Axiron (Eli Lilly) has German approval for Hypogonadism
Eli Lilly has received approval in Germany for Axiron (estosterone solution 2%) for testosterone replacement therapy for male Hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
The approval of Axiron in Germany was granted after the European decentralised procedure was closed with a positive recommendation on the drug.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.